Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/2DT stock hub

FRA/2DT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/2DTis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.6B
Frankfurt Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
FRA/2DT
In the news

Latest news · FRA/2DT

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.6
P25 n/aP50 n/aP75 n/a
Trailing P/E33.8
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC15.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/2DT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
196
Groups with data
11
Currency
USD
Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
8,700
Employees Change
450%
Employees Change Percent
5.73
Enterprise value
EUR 5.8B
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
EUR 3.6B
Price
EUR 11.4
Price currency
EUR
Rev Per Employee
303,640.63x
Sic
2834
Symbol
fra/2DT
Website
https://www.amneal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
2.96%
EV Earnings
54.49x
EV/EBIT
14.73x
EV/EBITDA
9.89x
EV/FCF
32.1x
EV/Sales
2.23x
FCF yield
5.02%
Forward P/E
11.62x
P/B ratio
103.28x
P/E ratio
33.78x
P/S ratio
1.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
15.14%
EBITDA Margin
21.92%
FCF margin
6.8%
Gross margin
39.16%
Gross Profit
EUR 1B
Gross Profit Growth
11.12%
Gross Profit Growth Q
13.32%
Gross Profit Growth3 Y
12.55%
Gross Profit Growth5 Y
11.58%
Net Income
EUR 105.9M
Net Income Growth5 Y
-4.57%
Pretax Margin
5.97%
Profit Margin
4.01%
Profit Per Employee
EUR 12,174
ROA
8.35
Roa5y
4.94
ROCE
16.4
ROIC
15.95
Roic5y
9.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr1y
90.08%
Cagr3y
90.43%
Cagr5y
19.39%
EPS Growth5 Y
-18.45
FCF Growth
2.72%
FCF Growth Q
-8.86%
FCF Growth3 Y
145.46%
FCF Growth5 Y
-5.33%
OCF Growth
15.21%
OCF Growth Q
10.36%
OCF Growth3 Y
73.5%
OCF Growth5 Y
-2.15%
Revenue Growth
8.05x
Revenue Growth Q
11.47x
Revenue Growth3 Y
10.92x
Revenue Growth5 Y
8.66x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.88
Assets
EUR 3.1B
Cash
EUR 174M
Current Assets
EUR 1.6B
Current Liabilities
EUR 747.6M
Debt
EUR 2.3B
Debt EBITDA
EUR 3.92
Debt Equity
EUR 67.51
Debt FCF
EUR 13.01
Equity
EUR 34.6M
Interest Coverage
1.94
Liabilities
EUR 3B
Long Term Assets
EUR 1.4B
Long Term Liabilities
EUR 2.3B
Net Cash
EUR -2.2B
Net Cash By Market Cap
EUR -60.5
Net Debt EBITDA
EUR 3.74
Net Debt Equity
EUR 62.49
Net Debt FCF
EUR 12.04
Tangible Book Value
EUR -1B
Tangible Book Value Per Share
EUR -3.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.47
Inventory Turnover
2.98
Net Working Capital
EUR 772.5M
Quick ratio
1.52
Working Capital
EUR 927.9M
Working Capital Turnover
EUR 3.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-5.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
90%
200-day SMA
9.74
3Y total return
590.91%
50-day SMA
10.72
50-day SMA vs 200-day SMA
50over200
5Y total return
142.55%
All Time High
20.47
All Time High Change
-44.31%
All Time High Date
2018-09-10
All Time Low
1.16
All Time Low Change
882.76%
All Time Low Date
2023-03-29
ATR
0.33
Ch YTD
6.54
High
11.4
High52
12.6
High52 Date
2026-02-19
High52ch
-9.52%
Low
11.2
Low52
6.1
Low52 Date
2025-05-08
Low52ch
90%
Ma50ch
6.3%
Price vs 200-day SMA
17.07%
RSI
58.48
RSI Monthly
70.07
RSI Weekly
59.56
Sharpe ratio
1.66x
Sortino ratio
2.82
Total Return
-5.12%
Tr YTD
6.54
Tr1m
11.77%
Tr1w
7.55%
Tr3m
-7.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 400M
Operating Income Growth
20.76
Operating Income Growth Q
46.73
Operating Income Growth3 Y
28.12
Operating Income Growth5 Y
23.63
Operating margin
15.14

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
178,432,130%
Net Borrowing
91,248,342.9
Shares Insiders
43.97%
Shares Institutions
53.09%
Shares Qo Q
1.03%
Shares Yo Y
5.12%
Short Ratio
4.56

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
EUR 150.7M
Average Volume
8.75x
Bv Per Share
-0.12
CAPEX
EUR -85.5M
Ch1m
11.77
Ch1w
7.55
Ch1y
90
Ch3m
-7.32
Ch3y
590.9
Ch5y
142.6
Ch6m
16.33
Change
0.88%
Change From Open
1.79
Close
11.3
Days Gap
-0.88
Depreciation Amortization
189,580,560.3
Earnings Date
2026-05-01
EBIT
EUR 400M
EBITDA
EUR 579.2M
EPS
EUR 0.32
F Score
7
FCF
EUR 179.8M
FCF EV Yield
3.11x
Financing CF
-44,595,699
Fiscal Year End
December
Founded
2,002
Goodwill
504,935,932.1
Graham Number
0.91552
Graham Upside
-91.97
Income Tax
EUR 506,503
Investing CF
-100,758,578
Is Primary Listing
0
Last Earnings Date
2026-05-01
Last Report Date
2025-12-31
Lynch Fair Value
EUR 1.69
Lynch Upside
-85.2
Ma150
10.42
Ma150ch
9.43%
Ma20
10.83
Ma20ch
5.26%
Net CF
117,964,942
Next Earnings Date
2026-08-07
Open
11.2
P FCF Ratio
19.9
P OCF Ratio
13.49
Position In Range
100
Ppne
466,655,535.6
Price Date
2026-05-08
Price EBITDA
EUR 6.18
Relative Volume
20x
Revenue
2,641,673,511x
SBC By Revenue
1.1x
Share Based Comp
29,064,090
Tax By Revenue
0.02x
Tax Rate
0.32%
Tr6m
16.33%
Z Score
2.02
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/2DT pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/2DT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+90.0%
S&P 500 1Y: n/a
3Y total return
+590.9%
S&P 500 3Y: n/a
5Y total return
+142.6%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/2DT?

Insider, institutional, and short-interest positioning.

Institutional ownership
+53.1%
Share of float held by funds and institutions
Insider ownership
+44.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.6 days to cover
Y/Y dilution
+5.1%
Negative means the company is buying back shares.
Technical

FRA/2DT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
58.5
Neutral momentum band
Price vs 200-day MA
+17.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.66
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/2DT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/2DT stock rating?

fra/2DT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/2DT analysis?

The full report lives at /stocks/fra/2DT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/2DT?

The latest report frames fra/2DT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/2DT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

fra/2DT stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام